Nine months later, those advisers are meeting to discuss booster shots, and the situation is very different. It won’t be a slam dunk. When this advisory committee meets on Friday, it will be presented with dueling data, some of it suggesting there’s a need for boosters, but other pieces of data suggesting there is no such need. The advisers will also likely debate the very essence of Covid-19 boosters — whether they would work and what they’re even supposed to accomplish in the first place. “This will be much messier than in December,” said Dr. William Schaffner, an infectious disease specialist at Vanderbilt University. Schaffner has been following the FDA deliberations closely, as he serves as member of an advisory committee to the US Centers

Read More At Article Source | Article Attribution